The effects of high haematocrit levels on glucose metabolism disorders

被引:8
作者
Çapoglu, I
Ünüvar, N
Bektas, Y
Yilmaz, Ö
Kaya, MD
机构
[1] Ataturk Univ, Fac Med, Div Endocrinol & Metab, Erzurum, Turkey
[2] Ataturk Univ, Fac Med, Div Pulm Dis, Erzurum, Turkey
[3] Ataturk Univ, Fac Med, Div Internal Med, Erzurum, Turkey
[4] Ataturk Univ, Vocat High Sch, Div Comp Programming, Erzurum, Turkey
关键词
type; 2; diabetes; impaired glucose tolerance; glucose metabolism disorder; haematocrit; chronic obstructive pulmonary disease (COPD);
D O I
10.1177/147323000203000411
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 [基础医学];
摘要
There has been only limited research investigating the possible association between raised haematocrit levels, glucose intolerance and type 2 diabetes. In the present study, we explored the association between high haematocrit levels and impaired glucose tolerance by performing oral glucose tolerance tests in 46 patients with chronic obstructive pulmonary disease and no previous history of diabetes mellitus or glucose intolerance. A glucose metabolism disorder was observed in 12 (26%) patients (type 2 diabetes in six patients and impaired glucose tolerance in a further six). There was a significant association between high haematocrit levels and the presence of a glucose metabolism disorder, which was independent of other risk factors. High haematocrit levels may be an independent risk factor for type 2 diabetes and impaired glucose tolerance.
引用
收藏
页码:433 / 437
页数:5
相关论文
共 16 条
[1]
Drug therapy - Metformin [J].
Bailey, CJ ;
Turner, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579
[2]
New aspects of the insulin resistance syndrome: impact on haematological parameters [J].
Barbieri, M ;
Ragno, E ;
Benvenuti, E ;
Zito, GA ;
Corsi, A ;
Ferrucci, L ;
Paolisso, G .
DIABETOLOGIA, 2001, 44 (10) :1232-1237
[3]
*COMM DIAGN STAND, 1987, AM REV RESPIR DIS, V85, P762
[4]
Gavin JR, 1997, DIABETES CARE, V20, P1183
[5]
Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease [J].
Incalzi, RA ;
Fuso, L ;
De Rosa, M ;
Forastiere, F ;
Rapiti, E ;
Nardecchia, B ;
Pistelli, R .
EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (12) :2794-2800
[6]
INSULIN-LIKE GROWTH FACTOR-I STIMULATES ERYTHROPOIESIS IN HYPOPHYSECTOMIZED RATS [J].
KURTZ, A ;
ZAPF, J ;
ECKARDT, KU ;
CLEMONS, G ;
FROESCH, ER ;
BAUER, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (20) :7825-7829
[7]
RELATIONSHIP BETWEEN HEMORRHEOLOGIC FACTORS AND INSULIN SENSITIVITY IN HEALTHY-YOUNG MEN [J].
MOAN, A ;
NORDBY, G ;
OS, I ;
BIRKELAND, KI ;
KJELDSEN, SE .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (04) :423-427
[8]
PROSPECTIVE-STUDY OF RISK-FACTORS FOR DEVELOPMENT OF NON-INSULIN-DEPENDENT DIABETES IN MIDDLE-AGED BRITISH MEN [J].
PERRY, IJ ;
WANNAMETHEE, SG ;
WALKER, MK ;
THOMSON, AG ;
WHINCUP, PH ;
SHAPER, AG .
BRITISH MEDICAL JOURNAL, 1995, 310 (6979) :560-564
[9]
GLUCOREGULATORY HORMONES IN MAN AT HIGH-ALTITUDE [J].
SAWHNEY, RC ;
MALHOTRA, AS ;
SINGH, T .
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY AND OCCUPATIONAL PHYSIOLOGY, 1991, 62 (04) :286-291
[10]
OPTIMAL ASSESSMENT AND MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE (COPD) [J].
SIAFAKAS, NM ;
VERMEIRE, P ;
PRIDE, NB ;
PAOLETTI, P ;
GIBSON, J ;
HOWARD, P ;
YERNAULT, JC ;
DECRAMER, M ;
HIGENBOTTAM, T ;
POSTMA, DS ;
REES, J .
EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (08) :1398-1420